Agelaki Sofia
May 9, 2025 2025-05-09 15:07Agelaki Sofia
Agelaki Sofia
Professor of Medical Oncology
Medical School, University of Crete, P.C. 71003 Heraklion, Crete
Dr. Agelaki specializes in the treatment of lung cancer and thoracic malignancies, focusing on providing personalized therapies tailored to each patient’s specific cancer profile and individual needs. She is also involved in the conduct of a multitude of international and national multicenter clinical trials in lung and breast cancer both as principal investigator or as a sub- investigator.
Dr. Agelaki dedicates significant effort to research, since she is a principal investigator at the Laboratory of Translational Oncology at the University of Crete. Her research interests focus on the evaluation of liquid biopsy components as a tool to improve patient risk stratification and disease monitoring in patients with cancer. Her research has generated several collaborations with leading academic institutions across Greece and Europe. Dr. Agelaki has published more than 160 articles in international peer reviewed journals and is solicited as reviewer for several scientific and medical journals. She presented more than 300 abstracts and was invited as a speaker or as a chairwoman in many Greek and International Scientific Meetings and conferences.
In addition to her teaching activities at the University of Crete, she was the director of the 6th Cycle of Studies of the educational program of the Hellenic Academy of Oncology (E.A.K.O) organized by the Hellenic Society of Medical Oncology (HeSMO). She is a member of the American Society for Clinical Oncology (ASCO), the European Society for Medical Oncology (ESMO) and the Hellenic Lung Cancer Society (EL.E.KA.P.) and other scientific organizations.
She served as General Secretary of the Board of Directors of HeSMO between 2017-2021, and currently is the General Secretary of the Hellenic Lung Cancer Society EL.E.KA.P.
2003: PhD, Department of Medicine, University of Crete, Greece. Thesis title “The role of synthetic corticotropin elicitor in the immune system”
1997-1998: Scientific Associate, Department of Medical Oncology, University General Hospital of Heraklion
1991-1997: Intern, Department of Internal Medicine, University General Hospital of Heraklion
1984 – 1990: Degree in Medicine, School of Medicine, University of Crete
Dr. Agelaki’s primary scientific interests focus on translational cancer research, with a particular emphasis on the role of liquid biopsy in the discovery of novel biomarkers and the investigation of mechanisms underlying metastasis.
Specifically, her research interests include:
1. Detection and Phenotypic Characterization of Circulating Tumor Cells (CTCs): Studying CTCs in cancer patients and evaluating their prognostic and predictive value.
2. Analysis of Circulating Nucleic Acids (ctDNA, miRNAs): Investigating their prognostic significance and exploring their role as tools for real-time therapeutic selection and disease monitoring.
3. Clinical Management of Patients with Lung, Breast, and Head and Neck Cancers: Conducting clinical investigations to optimize treatment strategies for these malignancies.
4. Efficacy of Novel Targeted Agents: Evaluating the therapeutic potential of new targeted treatments in cancer patients.
Dr. Agelaki’s work is at the forefront of translational oncology, contributing to the development of personalized medicine and advancing cancer treatment strategies.
1. American Association for Cancer Research (AACR)
2. American Society for Clinical Oncology (ASCO)
3. European Thoracic Oncology Group (ETOP)
4. Lung Cancer Group of EORTC (European Organization for Research and Treatment of Cancer)
5. Hellenic Society of Medical Oncology (HESMO)
6. Hellenic Association of Lung Cancer (ELEKAP)
7. Women for Oncology- Hellas (W4O – HELLAS)
8. European Liquid Biopsy Society (ELBS)
